tiprankstipranks
Dice Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyDice Therapeutics downgraded to Neutral from Buy at Guggenheim
1y ago
Dice Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Dice Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1y ago
Dice Therapeutics downgraded to Hold from Buy at Stifel
Premium
The Fly
Dice Therapeutics downgraded to Hold from Buy at Stifel
1y ago
DICE Surges after $2.4 Billion Acquisition by LLY
PremiumMarket NewsDICE Surges after $2.4 Billion Acquisition by LLY
1y ago
Eli Lilly to acquire Dice Therapeutics for $48 per share in cash
Premium
The Fly
Eli Lilly to acquire Dice Therapeutics for $48 per share in cash
1y ago
TipRanks ‘Perfect 10’ List: Don’t Overlook These 2 Top-Rated Stocks
Premium
Stock Analysis & Ideas
TipRanks ‘Perfect 10’ List: Don’t Overlook These 2 Top-Rated Stocks
2y ago
Cantor biopharma/biotech analysts hold analyst/industry conference call
PremiumThe FlyCantor biopharma/biotech analysts hold analyst/industry conference call
2y ago
Cantor biopharma/biotech analysts hold analyst/industry conference call
Premium
The Fly
Cantor biopharma/biotech analysts hold analyst/industry conference call
2y ago
Dice Therapeutics reports Q4 EPS (51c), consensus (49c)
Premium
The Fly
Dice Therapeutics reports Q4 EPS (51c), consensus (49c)
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100